Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Imeglimin Beneficial As Add-On to Metformin in T2DM
As add-on therapy, new oral agent improves glycemic control; generally well tolerated
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

July 28, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Delays Noted in the Reporting of Serious Patient Harms to FDA

FDA Approves Praluent for Certain Cases of High Cholesterol

35% of Colorectal Cancers in Patients Age ≤35 Are Genetic

Neonatal Intensive Care May Be Overused

Beetroot Juice Supplementation May Help Lengthen Workouts

FDA Approves Odomzo for Recurring Basal Cell Carcinoma